Modulating STAT3 Signaling by Selective C5aR1 Inhibition: An In Silico Directed In Vitro Approach to Combat Diabetic Kidney Disease

Ayed A. Dera, Mesfer Al Shahrani

PDF(9029 KB)
For Authors|For Editors|For Reviewers
PDF(9029 KB)
Discovery Medicine ›› 2025, Vol. 37 ›› Issue (202) : 2539-2551. DOI: 10.24976/Discov.Med.202537202.213
Article

Modulating STAT3 Signaling by Selective C5aR1 Inhibition: An In Silico Directed In Vitro Approach to Combat Diabetic Kidney Disease

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

Highlight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2025, 37(202): 2539-2551 https://doi.org/10.24976/Discov.Med.202537202.213

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(9029 KB)

Accesses

Citation

Detail
Sections
Recommended
Follow Us on
Copyright © 2025.
By using this website, you agree to our Terms & Conditions and Privacy Policy.  
  • Disclaimer
    The statements, opinions and data contained in Discovery Medicine are solely those of the individual authors and contributors and not of the journal and the editor(s). Discovery Medicine stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

    • /

    〈 〉